GENinCode (LON:GENI) Releases Earnings Results

GENinCode (LON:GENI) announced its quarterly earnings data on Tuesday. The company reported GBX (0.38) earnings per share for the quarter, Digital Look Earnings reports. GENinCode had a negative return on equity of 409.40% and a negative net margin of 185.47%.

GENinCode Price Performance

Shares of LON GENI traded down GBX 0.17 during trading on Tuesday, hitting GBX 0.70. 22,954,143 shares of the company were exchanged, compared to its average volume of 5,146,545. The company has a debt-to-equity ratio of 117.74, a current ratio of 0.93 and a quick ratio of 15.88. GENinCode has a 1 year low of GBX 0.64 and a 1 year high of GBX 4.90. The company has a market cap of £5.27 million, a price-to-earnings ratio of -0.34 and a beta of 0.59. The firm’s fifty day moving average price is GBX 0.88 and its 200 day moving average price is GBX 0.99.

About GENinCode

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.